Effectiveness for macular pigment with lutein supplementation in central serous chorioretinopathy

Effectiveness for macular pigment with lutein supplementation in central serous chorioretinopathy - Effectiveness for macular pigment with lutein supplementation in central serous chorioretinopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005849

Enrollment

Registered

2011-06-26

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central serous chorioretinopathy

Interventions

supplement with lutein supplement without lutein

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Central serous chorioretinopathy eyes with subretinal fluid and leakage on fluorescein angiography 2)Japanese patient more than 30 years old

Exclusion criteria

Exclusion criteria: 1)Hard exudate or subretinal hemorrhage within subretinal fluid 2)Invisible fundus 3)Visual acuity less than 0.01 4)Difficulty to measure macular pigment 5)After vitrectomy 6)Past supplementaion with lutein

Design outcomes

Primary

Measure	Time frame
macular pigment and serum lutein	—

Countries

Japan

Contacts

Public ContactMiki Sawa

Osaka Univerisity Medical Hospital Ophthalmology

sawamiki@ophthal.med.osaka-u.ac.jp06-6879-3456

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026